[1] | Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood, 2011, 118(13): 3479-3488. | [2] | Weatherall EJ, Clegg JB. The Thalassemia Syndromes. Oxford: Blackwell Science, 2001. | [3] | Hahn CK, Lowrey CH. Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA. Blood, 2014, 124(17): 2730-2734. | [4] | Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DHK, Steinberg MH. Fetal hemoglobin in sickle cell anemia. Blood, 2011, 118(1): 19-27. | [5] | Van Dijk TB, Gillemans N, Pourfarzad F, van Lom K, von Lindern M, Grosveld F, Philipsen S. Fetal globin expression is regulated by Friend of Prmt1. Blood, 2010, 116(20): 4349-4352. | [6] | Guo XQ. Progress on genes related to fetal hemoglobin quantitative trait. Hereditas (Beijing), 2010, 32(4): 295-300. | [6] | 郭晓强. 胎儿血红蛋白数量性状相关基因的研究进展. 遗传, 2010, 32(4): 295-300. | [7] | Galanello R, Sanna S, Perseu L, Sollaino MC, Satta S, Lai ME, Barella S, Uda M, Usala G, Abecasis GR, Cao A. Amelioration of Sardinian β0 thalassemia by genetic modifiers. Blood, 2009, 114(18): 3935-3937. | [8] | Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G, Pissard S, Joly P, Thuret I, Origa R, Borg J, Forni GL, Piga A, Lai ME, Badens C, Moi P, Galanello R. A genetic score for the prediction of beta-thalassemia severity. Haematologica, 2015, 100(4): 452-457. | [9] | Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello R. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica, 2012, 97(7): 989-993. | [10] | Bauer DE, Orkin SH. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin. Curr Opin Genet Dev, 2015, 33: 62-70. | [11] | Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao HL, Trowbridge JJ, Mandel G, Orkin SH. Corepressor- dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci USA, 2013, 110(16): 6518-6523. | [12] | Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, Fisher C, Suciu M, Martyn GE, Norton LJ, Zhu C, Kurita R, Nakamura Y, Xu J, Higgs DR, Crossley M, Bauer DE, Orkin SH, Kharchenko PV, Maeda T. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science, 2016, 351(6270): 285-289. | [13] | Liu D, Zhang XH, Yu LH, Cai R, Ma XX, Zheng CG, Zhou YQ, Liu QJ, Wei XF, Lin L, Yan TZ, Huang JW, Mohandas N, An XL, Xu XM. KLF1 mutations are relatively more common in a thalassemia endemic region |
[1] |
李凯伦, 卢荆奥, 陈小辉, 张文清, 刘伟. 尿囊素促进破骨细胞缺陷斑马鱼骨折修复[J]. 遗传, 2023, 45(4): 341-353. |
[2] |
龚一鸣, 王翔宇, 贺小云, 刘玉芳, 余平, 储明星, 狄冉. 绵羊FecB突变对BMPR1B活性及BMP/SMAD通路的影响研究进展[J]. 遗传, 2023, 45(4): 295-305. |
[3] |
马捷, 黄露杰, 张巧霞, 朱艳, 钱露. 以A2型短指(趾)症为案例的医学遗传学PBL教学设计[J]. 遗传, 2023, 45(2): 176-183. |
[4] |
李璐阳, 刘孙强, 施云, 赵成程, 周红文, 郑旭琴. 一例葡萄糖激酶基因突变致低血糖症的诊疗及家系遗传分析[J]. 遗传, 2022, 44(9): 810-818. |
[5] |
张充, 魏子璇, 王敏, 陈瑶生, 何祖勇. 利用CRISPR/Cas9在人类黑色素瘤细胞中编辑MC1R与功能分析[J]. 遗传, 2022, 44(7): 581-590. |
[6] |
宋绍征, 何正义, 成勇, 于宝利, 张婷, 李丹. TALENs介导MSTN基因突变山羊的制备及性能分析[J]. 遗传, 2022, 44(6): 531-542. |
[7] |
宋青青, 张素素, 张振, 孙嘉, 杨锐, 李佶桐, 陈宏. 一例CYP11B基因突变导致11β-羟化酶缺乏症的诊疗和基因检测分析[J]. 遗传, 2022, 44(12): 1175-1182. |
[8] |
王思琪, 陈阳, 罗宽宏, 史宁杰, 肖康丽, 崔振海, 曾天舒, 黎慧清. 一例SOX10基因缺失所致的Waardenburg综合征2型合并低促性腺激素性性腺功能减退症的诊断和基因检测分析[J]. 遗传, 2022, 44(12): 1158-1166. |
[9] |
贾觉睿智, 肖诚, 刘艺文, 李冉, 张化冰, 于淼. 二例GCK基因突变致先天性高胰岛素性低血糖症的诊疗和基因检测分析[J]. 遗传, 2022, 44(11): 1056-1062. |
[10] |
肖诚, 刘洁颖, 杨春如, 于淼. LMNA基因突变相关脂肪萎缩综合征的研究进展[J]. 遗传, 2022, 44(10): 913-925. |
[11] |
蒋琬姿, 张丽雯, 贺彩红, 阮梅花, 季勇, 于建荣, 周红文. 家族性高胆固醇血症研究进展[J]. 遗传, 2021, 43(11): 1011-1022. |
[12] |
刘志勇, 任贺, 陈冲, 张京晶, 张晓梦, 石妍, 石林玉, 陈滢, 程凤, 贾莉, 陈曼, 范庆炜, 张家榕, 李万婷, 王萌春, 任子林, 刘雅诚, 倪铭, 孙宏钰, 严江伟. 基于有限突变模型和大规模数据的19个常染色体STR的实际突变率研究[J]. 遗传, 2021, 43(10): 949-961. |
[13] |
赵利楠, 王娜, 杨国良, 苏现斌, 韩泽广. 基于单细胞靶向测序探究基因碱基突变的方法[J]. 遗传, 2020, 42(7): 703-712. |
[14] |
程苗苗, 曹延延. NMD逃逸机制及其在疾病治疗中的应用[J]. 遗传, 2020, 42(4): 354-362. |
[15] |
朱海美, 黄鹏程, 赵田田, 周长慧, 李若婉, 于春荣, 陈志勇, 顾林峰, 常艳. 纳米银颗粒及纳米二氧化钛颗粒的体外遗传毒性研究[J]. 遗传, 2020, 42(12): 1192-1200. |
|